Universe Pharmaceuticals Inc (UPC) — Capital Reinvestment Ratio
Universe Pharmaceuticals Inc (UPC) has a Capital Reinvestment Ratio of 0.04x as of March 2025, meaning it reinvests 0% of its operating cash flow ($2.56 Million) in capital expenditures ($96.78K). Check Universe Pharmaceuticals Inc (UPC) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Universe Pharmaceuticals Inc Capital Reinvestment Ratio (2018–2023)
This chart tracks Universe Pharmaceuticals Inc's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see UPC operating cash flow.
Annual Capital Reinvestment Ratio for Universe Pharmaceuticals Inc (2018–2023)
Year-by-year Capital Reinvestment Ratio for Universe Pharmaceuticals Inc from 2018 to 2023. See Universe Pharmaceuticals Inc (UPC) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | $1.12 Million | $44.17K | ▲ +365.6% |
| 2020 | 0.01x | $6.12 Million | $51.80K | ▲ +29.6% |
| 2019 | 0.01x | $13.20 Million | $86.32K | ▼ -79.9% |
| 2018 | 0.03x | $4.46 Million | $145.09K | — |